India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
Yes Bank 12.86
Axis Ban 798.20 6.50
Tata Mot 317.95
Ong Corp 136.05 7.42
Bharti A 739.20 37.79
Clear All Clear Last
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
FII Activity
Mutual Fund Activity
Results Watch
Results Calendar
Results Announced
IPO Watch
Recent News
Broker Research
Research Tutorial
Discussion Forum
Research Reports
News Watch
Sector Watch
Economy Watch
News-Cipla Limited
Cipla Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
Market Lot: 1Face Value: 2ISIN Demat: INE059A01026
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

Corporate News
21-Sep-2021       Cipla rises on subscribing 5% stake in Swasth Digital Health Foundation IRIS
12-Aug-2021       Cipla gets USFDA final nod for Difluprednate Ophthalmic Emulsion  IRIS
23-Jun-2021       Cipla receives final approval for Arformoterol Tartrate Inhalation Solution  IRIS
20-May-2021       Cipla launches RT-PCR test kit ViraGen for COVID-19 IRIS
10-May-2021       Cipla inches up on signing licensing pact with Eli Lilly IRIS
05-May-2021       Cipla???s associate company incorporates wholly-owned subsidiary IRIS
29-Apr-2021       Cipla enters into licensing agreement with MSD  IRIS
31-Mar-2021       Cipla enters into pact to become partner in ABCD Technologies LLP IRIS
23-Mar-2021       Cipla in collaboration with SIGA Technologies  IRIS
03-Mar-2021       Cipla Gulf expands partnership with Alvotech  IRIS
27-Jan-2021       Cipla commissions 30 MW solar project in Maharashtra IRIS
16-Dec-2020       Cipla launches 'CIPtest' rapid antigen detection test for COVID-19 diagnosis IRIS
14-Dec-2020       Cipla settles its litigation with Celgene Corporation IRIS
26-Mar-2020       Cipla receives final approval for generic Esomeprazole for oral suspension IRIS
26-Feb-2020       Cipla receives USFDA warning letter for Goa facility IRIS
19-Feb-2019       Cipla, Wellthy Therapeutics announce partnership to offer digital therapeutics IRIS
07-Feb-2019       Cipla gets final nod for Tadalafil tablets IRIS
28-Jan-2019       Cipla gets USFDA final approval for Medroxyprogesterone injectable IRIS
12-Nov-2018       Cipla gets USFDA final approval for Valganciclovir tablets IRIS
29-Oct-2018       Cipla receives USFDA final approval for Metoprolol ER tablets IRIS



Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited